Elequin Capital’s Elevance Health ELV Stock Holding History

Elequin Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9	Closed	-$4K	–	407
2022 Q1	$4K	Sell	9 -2	-18%	-$914	﹤0.01%	225
2021 Q4	$5K	Buy	+11	New	+$4.63K	﹤0.01%	17

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Elequin Capital's ELV Position: Q2 2022 in Review

Elequin Capital sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 9 shares — an estimated $4K sold.

Elequin Capital first reported a position in ELV in Q4 2021 and held it in 2 quarters. The position peaked at $5K in Q4 2021. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

Elequin Capital reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
Elequin Capital sold 9 Elevance Health shares in Q2 2022, an estimated $4K.
Elequin Capital first reported a position in Elevance Health in Q4 2021 and held it in 2 quarters.
Elequin Capital's Elevance Health position peaked at $5K in Q4 2021.
1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Elequin Capital's 13F filing for Q2 2022, filed 11 Aug 2022.